Search

everythinglearnresearchcommunity

for

Search:↓

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

Endocrine diseases in children often cause skin changes like dryness, redness, acne, hair loss, and more.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Certain gene variations may increase the risk and severity of alopecia areata.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

New alopecia treatments aim for better results and fewer side effects.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Environmental cues can change the fate and function of epithelial cells, with potential for cell therapy.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Individualized treatment and psychological support are crucial for alopecia.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.